Aspirin for the prevention of preterm delivery in patients with prophylactic cervical cerclage

Aspirin for the prevention of preterm delivery in patients with cervical cerclage

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034662

Enrollment

Unknown

Registered

2020-07-13

Start date

2020-11-01

Completion date

Unknown

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preterm delivery

Interventions

experimental group:aspirin 75mg per day

control group:standard management

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women diagnosed as cervical insufficiency and planned to receive prophylactic cervical cerclage in our hospital at 12-14 weeks; or with cervical dilation or shorten and need to receive cerclage before 28 weeks; 2. Single pregnancy; 3. Age between 18 and 40 years.

Exclusion criteria

Exclusion criteria: 1. The pregnancy test indicated multiple fetal malformations; 2. Allergic to aspirin or contraindicated aspirin, such as digestive ulcer.

Design outcomes

Primary

Measure	Time frame
gestational week of delivery;	—

Secondary

Measure	Time frame
outcom of newborns;times of admitted in hospital;gestational complications;intrapartum hemorrage;postpartum hemorrage;	—

Countries

China

Contacts

Public ContactLuo Qiong

Women's Hospital, Zhejiang University School of Medicine

luoq@zju.edu.cn+86 139 5802 3267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026